Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

GLP1R gene

Known as: glucagon like peptide 1 receptor, GLP1 RECEPTOR, GLUCAGON-LIKE PEPTIDE 1 RECEPTOR 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Endogenous intestinal glucagon-like peptide-1 (GLP-1) controls satiation and glucose metabolism via vagal afferent neurons (VANs… Expand
2017
2017
Lipid lowering properties of glucagon have been reported. Blocking glucagon signaling leads to rise in plasma LDL levels. Here… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2015
2015
Background: Little is known about the interaction between GLP-1 and the heptahelical core domain of GLP1R. Results: GLP-1 Asp9… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
PurposeCopper-64 (Cu-64) and Galium-68 (Ga-68) radiolabeled DO3A and NODA conjugates of exendin-4 were used for preclinical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2014
2014
We previously showed that activated peroxisome proliferator-activated receptor (PPAR)β/δ can protect pancreatic β cells against… Expand
  • table 1
  • table 2
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2013
Highly Cited
2013
The glucagonlike peptide 1 receptor (GLP-1R) is mainly expressed on β-cells in the islets of Langerhans and is therefore an… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
We previously demonstrated that the overall incretin effect and the β-cell responsiveness to glucagon-like peptide-1 (GLP1) are… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2012
Highly Cited
2012
Aims/hypothesisIndividuals carrying type 2 diabetes risk alleles in TCF7L2 display decreased beta cell levels of T cell factor 7… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2010
Highly Cited
2010
Aims/hypothesisMetformin is widely used for the treatment of type 2 diabetes. Although it reduces hepatic glucose production… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Highly Cited
2009
Highly Cited
2009
Aims/hypothesisGlucagon-like peptide 1 (GLP-1) receptor (GLP-1R) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors attenuate… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2